EDAP TMS S.A. (FOCL)

Market Cap	164.92M +235.2%
Revenue (ttm)	74.07M +9.2%
Net Income	-30.89M
EPS	-0.82
Shares Out	37.48M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	42,185
Open	4.500
Previous Close	4.320
Day's Range	4.175 - 4.500
52-Week Range	1.210 - 5.100
Beta	-0.00
Analysts	Buy
Price Target	5.83 (+32.5%)
Earnings Date	Aug 27, 2026

About FOCL

EDAP TMS S.A., a medical technology company, engages in the development, manufacturing, marketing, and sale of non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU segment develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications. This segment also offers Fo...

• Industry: Other
• Founded: 1979
• Employees: 289
• Stock Exchange: NASDAQ
• Ticker Symbol: FOCL
• Website: https://focalone.com

Financial Performance

In 2025, EDAP TMS's revenue was $70.53 million, an increase of 1.63% compared to the previous year's $69.40 million. Losses were -$29.25 million, 42.1% more than in 2024.

Analyst Summary

According to 3 analysts, the average rating for FOCL stock is "Buy." The 12-month stock price target is $5.83, which is an increase of 32.50% from the latest price.

Price Target

$5.83

(32.50% upside)

Analyst Consensus: Buy